Aarti Pharmalabs Ltd
Aarti Pharmalabs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Aarti Pharmalabs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Aarti Pharmalabs Ltd Share Price Chart
AARTIPHARM at 02 Nov 2026 12:22 PM Pharmaceuticals
886.50 +13.80(+1.58%)
Lowest Today 870.05
Highest Today 898.55
Today's Open 873.20
Prev. Close 872.70
52 Week High 1002.40
52 Week Low 574.45
Aarti Pharmalabs Ltd Fundamentals
Traded Volume: 2,07,093
Market Cap(Cr): 8,038.77
Avg Traded Price 886.75
1 Year return 6.21%
Upper Circuit 898.5
Lower Circuit 870
P/E TTM 31.00
P/B Ratio 3.724
Traded Value(Cr) 1835.88
EPS TTM 28.308
Book value/Share 234.350
Dividend Yield 1Y 0.40%
Aarti Pharmalabs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Aarti Pharmalabs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Aarti Pharmalabs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +8.00%
1M -7.05%
3M +31.47%
1Y +6.21%
YTD +17.27%
Aarti Pharmalabs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Aarti Pharmalabs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 6.43L
Day Before Yesterday 34.82L
1W Avg 10.95L
1M Avg 6.85L
3M Avg 9.54L
Aarti Pharmalabs Ltd Technical Details
Aarti Pharmalabs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 846
Support 2 819
Support 3 773
Pivot Point : 892
Resistance 1 919
Resistance 2 965
Resistance 3 992
Aarti Pharmalabs Ltd Corporate Actions
Aarti Pharmalabs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Aarti Pharmalabs Ltd’s capital allocation strategies.
All
Ex-Date 15-Sep-2026 Type D Description 2.00/share@40.00% Record Date 15-Sep-2026 Ratio 40.00
Ex-Date 16-Feb-2026 Type D Description 1.50/share@30.00% Record Date 16-Feb-2026 Ratio 30.00
Ex-Date 15-Sep-2025 Type D Description 2.50/share@50.00% Record Date 15-Sep-2025 Ratio 50.00
Ex-Date 14-Feb-2025 Type D Description 2.50/share@50.00% Record Date 14-Feb-2025 Ratio 50.00
Ex-Date 31-Jul-2024 Type D Description 1.00/share@20.00% Record Date 31-Jul-2024 Ratio 20.00
Ex-Date 16-Feb-2024 Type D Description 2.00/share@40.00% Record Date 19-Feb-2024 Ratio 40.00
Dividends
Announcement Date 15-Sep-2026 Ex Dividend Date 15-Sep-2026 Dividend(%) 40
Announcement Date 16-Feb-2026 Ex Dividend Date 16-Feb-2026 Dividend(%) 30
Announcement Date 15-Sep-2025 Ex Dividend Date 15-Sep-2025 Dividend(%) 50
Announcement Date 14-Feb-2025 Ex Dividend Date 14-Feb-2025 Dividend(%) 50
Announcement Date 31-Jul-2024 Ex Dividend Date 31-Jul-2024 Dividend(%) 20
Announcement Date 16-Feb-2024 Ex Dividend Date 16-Feb-2024 Dividend(%) 40
Bonus
No Bonus has been declared by AARTIPHARM
Splits
No Split has been declared by AARTIPHARM
Others
Rights No Rights has been declared by AARTIPHARM
Aarti Pharmalabs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Aarti Pharmalabs Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Aarti Pharmalabs Ltd's relative performance and valuation against major competitors.
Stock Name Blue Jet Healthcare Ltd ₹497.60 (-1.38%) M. Cap (Cr) 94.18 1 Yr Return (%) -23.13% P/E (TTM) 36.83 PB Ratio 6.02
Stock Name Symbiotec Pharmalab Ltd ₹1242.70 (-0.29%) M. Cap (Cr) 79.85 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 6.94
Stock Name Sanofi Consumer Healthcare India Ltd ₹3505.00 (+1.82%) M. Cap (Cr) 80.72 1 Yr Return (%) -24.55% P/E (TTM) 28.88 PB Ratio 21.04
Stock Name Aarti Pharmalabs Ltd ₹886.50 (+1.58%) M. Cap (Cr) 80.39 1 Yr Return (%) +6.21% P/E (TTM) 31.30 PB Ratio 3.66
Stock Name Sanofi India Ltd ₹3305.70 (+3.17%) M. Cap (Cr) 76.13 1 Yr Return (%) -31.23% P/E (TTM) 20.91 PB Ratio 9.94
Stock Name Bliss GVS Pharma Ltd ₹635.95 (-1.78%) M. Cap (Cr) 67.65 1 Yr Return (%) +307.29% P/E (TTM) 42.10 PB Ratio 5.45
Stock Name Supriya Lifescience Ltd ₹837.45 (-1.16%) M. Cap (Cr) 67.40 1 Yr Return (%) +11.44% P/E (TTM) 34.03 PB Ratio 5.52
Aarti Pharmalabs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Aarti Pharmalabs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 257.26 Mar 2025 340.01 Mar 2024 183.69 Mar 2023 228.69 Mar 2022 -64.84
PARTICULARS Investing Activities Mar 2026 -425.14 Mar 2025 -419.80 Mar 2024 -184.40 Mar 2023 -115.55 Mar 2022 -133.54
PARTICULARS Financing Activities Mar 2026 170.58 Mar 2025 78.63 Mar 2024 4.40 Mar 2023 -156.53 Mar 2022 254.63
PARTICULARS Net Cash Flow Mar 2026 2.70 Mar 2025 -1.16 Mar 2024 3.70 Mar 2023 -43.39 Mar 2022 56.25
Aarti Pharmalabs Ltd Shareholding Pattern
This shows the ownership breakdown of Aarti Pharmalabs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 39.66%
Public 43.78%
Other Institutions 7.81%
FII 8.16%
Mutual Funds 0.6%
About Aarti Pharmalabs Ltd
Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited in July, 2021 and again to Aarti Pharmalabs Limited in 2022. The Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), CDMO services and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semi-commercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024 and to 9,000 MTPA in 2025. Atali greenfield facility Phase I commissioned operations in 2025-26.
Chairman Emeritus
Chandrakant V Gogri
Registered office Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195
FAX :91-22-6797 6666
Background
Incorporation Year 2019
Face Value ₹5.00
Market Lot 1
FAQs on Aarti Pharmalabs Ltd
How to buy Aarti Pharmalabs Ltd shares?
To buy Aarti Pharmalabs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Aarti Pharmalabs Ltd?
The company has a market capitalization of ₹8,038.77.
What is the PE & PB ratio of Aarti Pharmalabs Ltd?
PE is 31 and PB is 3.724.
What is the Aarti Pharmalabs Ltd dividend for 2025–26?
For the 2025–26 financial year, Aarti Pharmalabs Ltd declared a final dividend of 0.40% per share.